Articles by Disease (Head And Neck Cancers)

Relaxin: New Functions for an Old Peptide

Journal: Current Protein & Peptide Science
Volume: 5
Page: 9-18
Author(s): M.C. Baccari and F. Calamai

Angiogenesis Inhibitors: Current & Future Directions

Journal: Current Pharmaceutical Design
Volume: 10
Page: 1-9
Author(s): Shaker A. Mousa and Ahmed S. Mousa

Angiogenesis: A Target for Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 10
Page: 11-26
Author(s): Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello

Antiangiogenic Therapy

Journal: Current Pharmaceutical Design
Volume: 10
Page: 27-37
Author(s): Daniel Albo, Thomas N. Wang and George P. Tuszynski

Molecular Targeting of Lymphatics for Therapy

Journal: Current Pharmaceutical Design
Volume: 10
Page: 65-74
Author(s): S. A. Stacker, R. A. Hughes and M. G. Achen

Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications

Journal: Current Pharmaceutical Design
Volume: 10
Page: 75-80
Author(s): Jorg Wilting and Lothar Schweigerer

Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine

Journal: Letters in Drug Design & Discovery
Volume: 1
Page: 45-49
Author(s): G. Ranieri, R. Patruno, G. Fiore, G. Saponaro, A. Paradiso and L. Grammatica

Novel Approaches for Modulating dUTPase and Uracil-DNA Glycosylase: Potential Uses for Cancer and Viral Chemotherapy

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1
Page: 1-13
Author(s): A. W. Studebaker, M. E. Ariza, G. K. Balendiran and M. V. Williams

Biosafety of Adenoviral Vectors

Journal: Current Gene Therapy
Volume: 3
Page: 527-543
Author(s): Marinee K.L. Chuah, Desire Collen and Thierry VandenDriessche

Phosphonomethoxyalkyl Analogs of Nucleotides

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2567-2592
Author(s): Antonin Holy